Recombinant multi-species Follistatin/FST protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Follistatin/FST protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Follistatin is a single-chain gonadal protein that specifically inhibits follicle-stimulating hormone release. The single FST gene encodes two isoforms, FST317 and FST344 containing 317 and 344 amino acids respectively, resulting from alternative splicing of the precursor mRNA. In a study in which 37 candidate genes were tested for linkage and association with polycystic ovary syndrome (PCOS) or hyperandrogenemia in 150 families, evidence was found for linkage between PCOS and follistatin. [provided by RefSeq, Jul 2008]
The Alternative Names of target: Activin-binding protein,FOL1,FS,FST,Follistatin,Fst,Fst-288,RATFOL1
Go
to Follistatin/FST products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T43901-Ag-1/ GM-Tg-hg-T43901-Ag-2 | Human Follistatin/FST protein | Human |
| GM-Tg-rg-T43901-Ag-1/ GM-Tg-rg-T43901-Ag-2 | Rat Follistatin/FST protein | Rat |
| GM-Tg-mg-T43901-Ag-1/ GM-Tg-mg-T43901-Ag-2 | Mouse Follistatin/FST protein | Mouse |
| GM-Tg-cynog-T43901-Ag-1/ GM-Tg-cynog-T43901-Ag-2 | Cynomolgus/Rhesus macaque Follistatin/FST protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T43901-Ag-1/ GM-Tg-felg-T43901-Ag-2 | Feline Follistatin/FST protein | Feline |
| GM-Tg-cang-T43901-Ag-1/ GM-Tg-cang-T43901-Ag-2 | Canine Follistatin/FST protein | Canine |
| GM-Tg-bovg-T43901-Ag-1/ GM-Tg-bovg-T43901-Ag-2 | Bovine Follistatin/FST protein | Bovine |
| GM-Tg-equg-T43901-Ag-1/ GM-Tg-equg-T43901-Ag-2 | Equine Follistatin/FST protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T43901-Ag-1/ GM-Tg-hg-T43901-Ag-2;
GM-Tg-rg-T43901-Ag-1/ GM-Tg-rg-T43901-Ag-2;
GM-Tg-mg-T43901-Ag-1/ GM-Tg-mg-T43901-Ag-2; GM-Tg-cynog-T43901-Ag-1/ GM-Tg-cynog-T43901-Ag-2; GM-Tg-felg-T43901-Ag-1/ GM-Tg-felg-T43901-Ag-2; GM-Tg-cang-T43901-Ag-1/ GM-Tg-cang-T43901-Ag-2; GM-Tg-bovg-T43901-Ag-1/ GM-Tg-bovg-T43901-Ag-2; GM-Tg-equg-T43901-Ag-1/ GM-Tg-equg-T43901-Ag-2 |
| Products Name | Follistatin/FST protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Follistatin/FST |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Follistatin/FST protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.